Browsing: Alzheimers
Alzheimer’s disease is characterized by the accumulation of two proteins in the brain: amyloid-beta and tau. Tau normally stabilizes the…
Elderly people with a genetic risk for Alzheimer’s disease did not experience the expected increase in cognitive decline and dementia…
Programs matching caregivers with patient navigators yield better results than Alzheimer’s drug – but a combination of the two may…
The Alzheimer’s Global Platform Foundation® (GAP) is pleased to welcome Spear Bio, a biotechnology company pioneering wash-free ultrasensitive immunoassay technology,…
For more than a century, Alzheimer’s disease (AD) has been considered irreversible. Consequently, research has focused on preventing or slowing…
Alzheimer’s disease presents one of the most important health challenges we face today. With more than 55 million people worldwide…
A new study led by ICAHN School of Medicine on Mount Sinai offers one of the most comprehensive views on…
The new study reveals that immune cells attack the nerve fibers of the brain associated with the smell, making the…
The intestine contains the largest collection of immune cells in the body. The new study at the Buck Institute shows…
What is the early spark that ignings the course of Alzheimer’s disease? Why do some people with alzheimer’s brain -like…